Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

1.65
Delayed Data
As of Jan 16
 +0.04 / +2.48%
Today’s Change
0.73
Today|||52-Week Range
2.14
+33.06%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close1.61
Today’s open1.68
Day’s range1.64 - 1.73
Volume10,845,428
Average volume (3 months)6,851,342
Market cap$504.9M
Data as of 3:59pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+39.69%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.08-2.07%
EDGEEdge Therapeutics In...-0.42-3.90%
BTXBioTime Inc-0.04-1.49%
RIGLRigel Pharmaceutical...-0.08-1.97%
Data as of 8:00pm ET, 01/16/2018

Financials

Next reporting dateFebruary 26, 2018
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Financial Officer &
Director
Stanley C. Erck
Senior VP-
Global Manufacturing Operations
Timothy Jon Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts